Eptifibatide (AuroMedics Pharma LLC)


Welcome to the PulseAid listing for the Eptifibatide drug offered from AuroMedics Pharma LLC. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AuroMedics Pharma LLC
NON-PROPRIETARY NAME: Eptifibatide
SUBSTANCE NAME: EPTIFIBATIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-12-08
END MARKETING DATE: 0000-00-00


Eptifibatide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEptifibatide from AuroMedics Pharma LLC
LABELER NAME: AuroMedics Pharma LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 75(mg/100mL)
START MARKETING DATE: 2015-12-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55150-218_af432eeb-dd03-4b5d-b57d-85b9abe09705
PRODUCT NDC: 55150-218
APPLICATION NUMBER: ANDA206127

Other EPTIFIBATIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Eptifibatide
Amneal BiosciencesEptifibatide
Aurobindo Pharma LimitedEptifibatide
AuroMedics Pharma LLCEptifibatide
Merck Sharp & Dohme Corp.Integrilin
Teva Parenteral Medicines, Inc.Eptifibatide